
Neogap fully takes over TCER Oncology shares
Neogap Therapeutics A/B was joined by new shareholders Prof. Rolf Kiessling and his team member Stina Wickström who took over the remaining...

Dutch NLC has €20m in first close of new Health Impact Fund
According to NLC, there's a huge funding gap that prevents patents from becoming successful companies, with 95% of all healthtech inventions never...

PureTech Health gets US$11.4m to advance LYT-300
PureTech Health plc has been awarded up to $11.4 million from the US government to advance LYT-300 (oral allopregnanolone) for the treatment of...

Santhera licences vamorolone rights to Catalyst Pharmaceuticals
Pratteln-based Santhera Pharmaceuticals Holding got a US$90m upfront payment from Catalyst Pharmaceuticals Inc for the Northern America vamorolone...

Novo Nordisk takes over Inversago Pharma Inc.
As competiion for Novo Nordisk A/S’ subcutanously administered blockbuster GLP1-receptor blocker semaglutide is growing, particularly as an obesity...

Pierre Fabre Laboratories collaborate with Vernalis
The French biotech company combines its experience in innovation, development, manufacturing, and commercialisation in oncology with the expertise of...

Lilly presents impressing results for Alzheimer's drug donanemab
Donanemab is the second antibody, after Eisai’s/Biogen’s accelarated approved lecanemab, that can slow the progression of dementia in early-stage...